09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601 3559<br />
Podnositelj europske MKP Broj objave europske Naziv izuma<br />
prijave patenta<br />
prijave patenta<br />
(71) (51) (97) (54)<br />
OOO "Andante", RU A61F 6/00 (2006.01)<br />
EP 2<strong>09</strong>4206 * CONDOM HOLDER<br />
A61F 6/04 (2006.01)<br />
Orsa S.r.l., IT A61H 1/00 (2006.01)<br />
A61H 1/02 (2006.01)<br />
EP 2<strong>09</strong>1496 *<br />
A63B 21/065 (2006.01)<br />
Osprey Pharmaceuticals USA, Inc., US C12N 15/62 (2006.01)<br />
A61K 47/48 (2006.01)<br />
A61P 11/00 (2006.01)<br />
A61P 29/00 (2006.01)<br />
A61P 37/06 (2006.01)<br />
C07K 14/245 (2006.01)<br />
C07K 14/25 (2006.01)<br />
C07K 14/475 (2006.01)<br />
C07K 14/52 (2006.01)<br />
C07K 16/00 (2006.01)<br />
C07K 19/00 (2006.01)<br />
C12N 1/21 (2006.01)<br />
C12N 15/13 (2006.01)<br />
C12N 15/18 (2006.01)<br />
C12N 15/19 (2006.01)<br />
C12N 15/56 (2006.01)<br />
C12N 15/63 (2006.01)<br />
C12N 9/24 (2006.01)<br />
C12P 21/02 (2006.01)<br />
C12Q 1/00 (2006.01)<br />
C12Q 1/68 (2006.01)<br />
OTSUKA PHARMACEUTICAL CO., C07D 317/58 (2006.01)<br />
LTD., JP<br />
C07D 405/12 (2006.01)<br />
Ovsyankin, Aleksey Vyacheslavovich, F03B 13/12 (2006.01)<br />
UA<br />
Ovsyankin, Vyacheslav Viktorovich, UA F03B 13/12 (2006.01)<br />
OWENS-BROCKWAY GLASS B65G 47/24 (2006.01)<br />
CONTAINER INC., US<br />
B65G 47/84 (2006.01)<br />
Owens-Brockway Glass Container Inc., C03B 9/16 (2006.01)<br />
US<br />
P.H.M. Philippe Morisse SAS, FR A63C 19/08 (2006.01)<br />
E01C 13/08 (2006.01)<br />
PAION Deutschland GmbH, DE A61K 38/00 (2006.01)<br />
A61P 9/10 (2006.01)<br />
A61P 7/02 (2006.01)<br />
Pantec Engineering AG, LI A61K 9/00 (2006.01)<br />
A61B 18/20 (2006.01)<br />
A61M 37/00 (2006.01)<br />
Paolucci, Stefano, IT E04H 6/10 (2006.01)<br />
EP 2<strong>09</strong>7529 *<br />
EP 2089373 *<br />
EP 2088312 *<br />
EP 2088312 *<br />
EP 2<strong>09</strong>4591 *<br />
EP 2<strong>09</strong>4614 *<br />
EP 2<strong>09</strong>9538 *<br />
EP 2014296<br />
EP 2<strong>09</strong>7062 *<br />
EP 2<strong>09</strong>2141 *<br />
Parodi, Alessandro, IT A41B 9/00 (2006.01)<br />
EP 2086362 *<br />
A41B 9/02 (2006.01)<br />
A41D 7/00 (2006.01)<br />
Pfizer Products Inc., US C07D 405/12 (2006.01)<br />
EP 2<strong>09</strong>7407 *<br />
C07D 3<strong>09</strong>/08 (2006.01)<br />
A61K 31/4155 (2006.01)<br />
A61P 11/00 (2006.01)<br />
Pfizer Products Inc., US C07D 491/107 (2006.01)<br />
EP 2<strong>09</strong>7420 *<br />
A61K 31/39 (2006.01)<br />
A61P 5/00 (2006.01)<br />
Pfizer Products Incorporated, US C07D 231/54 (2006.01)<br />
EP 2089367 *<br />
C07D 401/04 (2006.01)<br />
C07D 405/04 (2006.01)<br />
C07D 493/04 (2006.01)<br />
A61K 31/416 (2006.01)<br />
A61K 31/4162 (2006.01)<br />
A61P 9/12 (2006.01)<br />
PHARMACHEMIE B.V., NL A61J 3/07 (2006.01)<br />
EP 2<strong>09</strong>4224 *<br />
A61M 15/00 (2006.01)<br />
Pharmacopeia Inc., US C07D 401/14 (2006.01)<br />
EP 2<strong>09</strong>4688 *<br />
A61K 31/495 (2006.01)<br />
A61P 29/00 (2006.01)<br />
Pharmeste S.r.l., IT C07C 275/24 (2006.01)<br />
EP 2<strong>09</strong>4653 *<br />
A61K 31/17 (2006.01)<br />
A61P 29/00 (2006.01)<br />
Pierre Fabre Medicament, FR C07D 327/02 (2006.01)<br />
C07C 323/20 (2006.01)<br />
Pilkington North America, Inc., US B60J 1/18 (2006.01)<br />
Pilkington North America, Inc., US B60S 1/08 (2006.01)<br />
G01N 21/55 (2006.01)<br />
RELAXANT DEVICE OF MUSCLE FASCICLES IN THE<br />
CERVICAL DISTRICT<br />
METHODS OF SELECTING AND PRODUCING<br />
MODIFIED TOXINS, CONJUGATES CONTAINING<br />
MODIFIED TOXINS AND USES THEREOF<br />
STAT3/5 ACTIVATION INHIBITOR<br />
WAVE ELECTRIC POWER PLANT<br />
WAVE ELECTRIC POWER PLANT<br />
APPARATUS AND METHOD FOR ORIENTING NON-<br />
ROUND CONTAINERS<br />
INVERT MECHANISM FOR A GLASSWARE FORMING<br />
MACHINE<br />
PHOSPHORESCENT GROUND MARKING DEVICE<br />
Novel strategies for increasing the reperfusion in<br />
obstructed blood vessel<br />
WIDE-AREA PARASYSTEMIC TREATMENT OF SKIN<br />
RELATED CONDITIONS<br />
DEMOUNTABLE MODULAR STRUCTURE FOR HIGH-<br />
EFFICIENCY RAISED DECK PARKING LOTS WITH<br />
HERRINGBONE PARKING STALLS<br />
A MALE UNDERGARMENT<br />
PYRAZOLE ANALOGS<br />
SPIROKETONE ACETYL-COA CARBOXYLASE<br />
INHIBITORS<br />
PYRAZOLINE COMPOUNDS AS<br />
MINERALOCORTICOID RECEPTOR ANTAGONISTS<br />
CAPSULE, FILLED WITH A MEDICINE, IN<br />
PARTICULAR AN INHALABLE MEDICINE<br />
HETEROCYCLIC COMPOUNDS WITH CXCR3<br />
ANTAGONIST ACTIVITY<br />
O-SUBSTITUTED-DIBENZYL UREA-DERIVATIVES AS<br />
TRPV1 RECEPTOR ANTAGONISTS<br />
EP 2089374 * METHOD FOR THE SYNTHESIS OF N- [3- [ (2-<br />
METHOXYPHÉNYL) SULFANY] -2- METHYLPROPY]-<br />
3,4-DIHYDRO-2H-1,5-BENZOXATHIEPIN-3-AMINE.